MaxCyte Chairman Dr. Thompson not standing for re-election at Oct 29 meeting

MAXCYTE, INC.

Dr. J. Stark Thompson will not stand for re-election at the Annual Meeting on October 29, 2021.
He will serve as director and Chairman until the meeting; decision not related to any disagreement.
After meeting, board size will be eight members; a new Chairman will be appointed.
Thompson will continue as a consultant; his outstanding stock options will continue to vest.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

J. Stark Thompson

Chairman of the Board and Director

MXCT · MAXCYTE, INC.

Effective: 2021-10-29
Filed: October 1, 2021, 7:59 PM ET

On September 30, 2021, Dr. J. Stark Thompson notified the board of directors (the “ Board ”) of MaxCyte, Inc. (the “ Company ”) that he will not stand for re-election at the Annual Meeting of Stockholders to be held on October 29, 2021 (the “ Annual Meeting ”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

J. Stark Thompson departed as Chairman of the Board and Director at MAXCYTE, INC..

Action: will not stand for re-election
Role: Chairman of the Board and Director

Exact text from the filing

On September 30, 2021, Dr. J. Stark Thompson notified the board of directors (the “ Board ”) of MaxCyte, Inc. (the “ Company ”) that he will not stand for re-election at the Annual Meeting of Stockholders to be held on October 29, 2021 (the “ Annual Meeting ”).

View on SEC.gov

MAXCYTE, INC. filing history →

Source: SEC EDGAR

accession 0001104659-21-121662

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.